Company profile

Ezra

Medical Imaging & Radiology

Company profile

About Ezra

Ezra is a consumer-focused medical imaging company that provides advanced MRI and CT screening services for early detection of cancer and other serious health conditions. The company has united with Function to offer comprehensive preventive health screening that goes beyond traditional reactive healthcare. Ezra's flagship MRI scan examines up to 13 organs—including the brain, thyroid, liver, gallbladder, pancreas, spleen, kidneys, adrenal glands, bladder, ovaries, uterus, and prostate—in as little as 22 minutes. The company reports that 6% of their members have had potential cancer identified through their scans. Ezra offers multiple scan tiers ranging from a basic MRI scan ($999) to comprehensive packages including spine, musculoskeletal, and neurological assessments ($3,999), as well as specialized CT scans for heart and lung screening. The service is designed to be fast, affordable, and accessible, with results delivered within 7-10 days and interpreted by radiologists. Ezra uses FDA-cleared AI image enhancement technology and provides detailed reports with actionable findings. The company emphasizes early detection, noting that early-stage cancer has an 80% survival rate compared to less than 20% for late-stage cancer. Scans may be eligible for HSA/FSA reimbursement, and the company offers flexible monthly payment plans. Ezra partners with imaging centers across multiple locations and serves both individual consumers and corporate wellness programs.

Company description Ezra official website

Primary marketMedical Imaging & Radiology
Commercial modelCommercial information available on request
Company presenceLinkedIn X
Work at Ezra?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • Abdominal aortic aneurysm
  • Arthritis
  • Cancer (brain, thyroid, liver, gallbladder, pancreas, spleen, kidneys, adrenal glands, bladder, ovaries, uterus, prostate)
  • Cardiovascular disease
  • Cervical spinal stenosis
  • Emphysema
  • Fatty liver disease
  • Herniated discs
  • Lung cancer
  • Neurodegeneration
  • Scoliosis
  • Spinal lesions and tumors
  • Spondylosis
  • Stroke
  • Uterine fibroids

Who it serves

  • Employers
  • Healthcare providers
  • Imaging centers (B2B partners)
  • Individual consumers

Deployment & integration

Cloud Saas · Other deployment with recorded integration context.

Geographic context

MarketsUnited Kingdom · United States
Company sourceOfficial website

Company milestones

Platform expansion

United with Function to offer integrated preventive health screening services. Partnership program generating $10,000+ monthly revenue per imaging center location. 40% member return rate for annual scans.

Partnerships

Recorded partners

  • Function (merged/united for comprehensive health screening)
  • Hackensack Radiology Group
  • Smart Scan Medical Imaging

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

Ezra Hub Physician Platform

Platform for physicians to access and review patient scan results

Platform · Cloud SaaSCompany source

Heart CT Scan

5-minute low-dose CT scan measuring coronary artery calcium score for cardiovascular risk assessment

Service · OtherCompany source

Lung CT Scan

3-minute low-dose CT scan for early detection of lung cancer, nodules, and emphysema

Service · OtherCompany source

MRI Scan

22-minute full-body MRI screening for early cancer detection in up to 13 organs

Service · OtherCompany source

MRI Scan with Skeletal and Neurological Assessment

Comprehensive 2-session MRI with brain age analysis, musculoskeletal assessment, and body composition profiling

Service · OtherCompany source

MRI Scan with Spine

47-minute MRI scan including spine coverage for spinal lesions, herniated discs, and degenerative changes

Service · OtherCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

Evidence position

Publications, clinical validation, and regulatory records connected to this Company appear here.

Research

Publications & preprints

Common Scents: The Rationale for Preoperative Radiation in Esthesioneuroblastoma.

International journal of radiation oncology, biology, physics · Jul 1, 2026

Impact of metastasis-directed therapy for metachronous thoracic metastases following definitive (chemo)radiotherapy in p16-positive head and neck squamous cell carcinoma.

Oral oncology · Jul 1, 2026

Longevity and Volume Expansion of Hyaluronic Acid Dermal Fillers: A Cross-sectional 3-dimensional Magnetic Resonance Imaging Study.

Plastic and reconstructive surgery. Global open · Jul 1, 2026

Toward mechanistic virtual immune cells.

Nature biotechnology · Jun 25, 2026

Public support for mitochondrial donation: an Australian knowledge and attitudes study.

Reproductive biomedicine online · Jun 1, 2026

Contours and Confusions: A Review of Malar Mounds, Malar Edema, and Festoons.

The Journal of craniofacial surgery · May 21, 2026

Clinical validation

Clinical-trial records

Pembrolizumab in Treating Participants With Leukoplakia

NCT03603223 · Mentioned · RECRUITING

A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo

NCT07431177 · Mentioned · RECRUITING

Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)

NCT07116967 · Mentioned · RECRUITING

Autologous Platelet Concentrate (APC) in Intrabony Defects

NCT04254861 · Mentioned · RECRUITING

Periodontal Assessment of a Bariatric Care Population

NCT04851470 · Mentioned · RECRUITING

A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors

NCT06997029 · Mentioned · RECRUITING

Regulatory

Regulatory records

No linked records are currently available.

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

6% cancer detection rate

Percentage of members who had potential cancer identified through Ezra scans

80% survival rate for early detection

Early cancer detection vs <20% for late-stage cancer (American Cancer Society data)

7-10 day turnaround

Time to receive full Ezra Report after scan completion

Andrew

Detection of stage 3 kidney tumors on both kidneys in asymptomatic lifelong athlete

Early detection gave patient chance for longer life according to physician

Hackensack Radiology Group

Partnership to provide MRI screening services and generate cash-pay revenue

245 scans in 2025, 94 NPS score, steady volume increase, critical findings enabling early intervention

Holly

Proactive MRI scans caught cancer early twice

Early detection enabled successful treatment and health reclamation on two separate occasions

Patrick

Early detection of large brain tumor through preventive MRI screening

Tumor discovered 5-10 years earlier than it would have been without screening, potentially adding years of quality of life

Smart Scan Medical Imaging

Partnership to deliver high-quality imaging with elevated patient experience

125 scans in 2025, 94 NPS score, 4 Ezra sites, major value-driver for organization

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

No active leadership profiles are currently listed.

06 · Company updates

Updates from Ezra

Recent articles published on Ezra's official website.

No Company updates are currently listed.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Medical Imaging & Radiology

Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon